"Approximately 40% of the world's population remains at risk for iodine deficiency."
American Thyroid Association (ATA)
“It is estimated that 1.88 billion people worldwide remain at risk of insufficient iodine intake...”
World Health Organization, “Salt reduction and iodine fortification strategies in public health,” March 2013
GMP guidelines apply to every aspect of the manufacturing process, from the cleanliness of the equipment to the composition of our solutions themselves. GMP laboratory manufacturing also follows strict rules, regarding the handling, storage, and measurement of raw materials to ensure the composition and potency levels of products.
Iodine Prilled is considered a (REM) Rare Earth Metal. This rare natural resource requires particular attention in the GMP process. From specialized handling procedures, highly technical laboratory equipment, implementation of unique manufacturing processes, Iodine resistant equipment, physical location, and highly trained personnel, to name a few. Manufacturing a GMP Iodine-based suite of Lugol's Iodine Solutions is an achievement by itself!
The current marketplace for Iodine-based products is such that online sellers may omit critical information on their labels, because they have no way of obtaining it, or because it would expose their product's weaknesses. To protect from possible liability, some sellers are off-putting safety information or just add what looks like a legal disclaimer. Mentions such as "talisman only," "this product has not been evaluated by the U.S. Food & Drug Administration," "not intended for human usage," “for external use only,” or "Talisman usage" is commonly found on the internet.
Art Pharma® LUGOL'S IODINE is different; we are 100% transparent and consider it a privilege to serve consumers, resellers, and healthcare professionals. Product labels are displayed to website visitors without collecting or exchanging your information.
Enter your email to receive quality LUGOL’S IODINE SOLUTION information.